Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Briacell Therapeutics Corp (BCTXF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 12,323
  • Shares Outstanding, K 162,150
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 36-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.35
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0690 +10.14%
on 12/07/18
0.0930 -18.28%
on 11/16/18
-0.0070 (-8.43%)
since 11/08/18
3-Month
0.0690 +10.14%
on 12/07/18
0.1280 -40.63%
on 09/27/18
-0.0240 (-24.00%)
since 09/11/18
52-Week
0.0680 +11.76%
on 05/18/18
0.1387 -45.21%
on 12/13/17
-0.0311 (-29.04%)
since 12/11/17

Most Recent Stories

More News
BriaCell Presents Positive Efficacy Data with Lead Cancer Drug Candidate in Phase IIa Monotherapy and Excellent Initial Safety Data in Combination with KEYTRUDA(R) at a Major Breast Cancer Conference

-- Interim data indicate an excellent safety profile for the combination regimen in advanced breast cancer patients. Initial efficacy data is expected in first quarter of 2019;

BCTXF : 0.0760 (-5.00%)
BCT.VN : 0.090 (-10.00%)
MRK : 77.11 (-0.40%)
BriaCell to Present Updated Clinical Data Including Early Safety Data in KEYTRUDA(R) Combination Study and Positive Phase IIa Monotherapy Efficacy Data at 2018 San Antonio Breast Cancer Symposium

-- Positive proof of concept data with Bria-IMT(TM) Monotherapy will highlight potent anti-tumor activity and an excellent safety profile for Bria-IMT(TM) in advanced breast cancer.

BCTXF : 0.0760 (-5.00%)
BCT.VN : 0.090 (-10.00%)
MRK : 77.11 (-0.40%)
BriaCell Therapeutics Corp.'s CEO Talks Personalized Breast Cancer Treatment Technology with Uptick Newswire's Stock Day Podcast

BriaCell Therapeutics Corp. ("BriaCell," the "Company") (TSX-V: BCT) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, is pleased to...

BCTXF : 0.0760 (-5.00%)
BCT.VN : 0.090 (-10.00%)
NetworkNewsAudio Announces Audio Press Release (APR) on BriaCell Therapeutics Corp. Leveraging Combination Studies, Immune Checkpoint Inhibitors for Potent Anti-Cancer Response

NetworkNewsAudio announces the Audio Press Release (APR) titled "Personalized Immunotherapy Could Be the Future for Advanced Breast Cancer Treatment," featuring BriaCell Therapeutics Corp. (OTCQB: BCTXF)...

BCTXF : 0.0760 (-5.00%)
BCT.VN : 0.090 (-10.00%)
NetworkNewsAudio Announces Audio Press Release (APR) on BriaCell Therapeutics Corp. Achieving Superior Responses in Breast Cancer Immunotherapy Trials

NEW YORK, Oct. 04, 2018 (GLOBE NEWSWIRE) -- via NetworkWire - NetworkNewsAudio announces the Audio Press Release (APR) titled "Personalized Immunotherapy Could Be the Future for Advanced Breast Cancer...

BCTXF : 0.0760 (-5.00%)
BCT.VN : 0.090 (-10.00%)
NetworkNewsWire Announces Publication on Hope on the Horizon with Innovative Breast Cancer Therapies

NEW YORK, Oct. 03, 2018 (GLOBE NEWSWIRE) -- via NetworkWire -- NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring...

BCTXF : 0.0760 (-5.00%)
BCT.VN : 0.090 (-10.00%)
Personalized Immunotherapy Could be the Future for Advanced Breast Cancer Treatment

NetworkNewsWire Editorial Coverage

BCTXF : 0.0760 (-5.00%)
CMVLF : 20.7900 (unch)
BCT.VN : 0.090 (-10.00%)
NTGN : 5.61 (-1.41%)
LOXO : 137.37 (+1.47%)
GILD : 67.72 (+0.34%)
KITE : 179.99 (+0.11%)
CLLS : 20.07 (+3.61%)
IIROC Trade Resumption - BriaCell Therapeutics Corp.

Trading resumes in:

BCTXF : 0.0760 (-5.00%)
IIROC Trading Halt - BCT

The following issues have been halted by IIROC:

BCTXF : 0.0760 (-5.00%)
BCT.VN : 0.090 (-10.00%)
Coverage Initiated for BriaCell Therapeutics Corp. via NetworkNewsWire

via NetworkWire - BriaCell Therapeutics Corp. (OTCQB: BCTXF; TSX: BCT.V) (BriaCell or the Company), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology,...

BCTXF : 0.0760 (-5.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade BCTXF with:

Key Turning Points

2nd Resistance Point 0.0767
1st Resistance Point 0.0763
Last Price 0.0760
1st Support Level 0.0753
2nd Support Level 0.0747

See More

52-Week High 0.1387
Fibonacci 61.8% 0.1117
Fibonacci 50% 0.1033
Fibonacci 38.2% 0.0950
Last Price 0.0760
52-Week Low 0.0680

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar